Brain expression quantitative trait locus and network analysis reveals downstream effects and putative drivers for brain-related diseases

Gaining insight into the downstream consequences of non-coding variants is an essential step towards the identification of therapeutic targets from genome-wide association study (GWAS) findings. Here we have harmonized and integrated 8,727 RNA-seq samples with accompanying genotype data from multiple brain-regions from 14 datasets. This sample size enabled us to perform both cis - and trans -expression quantitative locus (eQTL) mapping. Upon comparing the brain cortex cis -eQTLs (for 12,307 unique genes at FDR<0.05) with a large blood cis- eQTL analysis (n=31,684 samples), we observed that brain eQTLs are more tissue specific than previously assumed. We inferred the brain cell type for 1,515 cis -eQTLs by using cell type proportion information. We conducted Mendelian Randomization on 31 brain-related traits using cis -eQTLs as instruments and found 159 significant findings that also passed colocalization. Furthermore, two multiple sclerosis (MS) findings had cell type specific signals, a neuron-specific cis- eQTL for CYP24A1 and a macrophage specific cis -eQTL for CLECL1 . To further interpret GWAS hits, we performed trans -eQTL analysis. We identified 2,589 trans -eQTLs (at FDR<0.05) for 373 unique SNPs, affecting 1,263 unique genes, and 21 replicated significantly using single-nucleus RNA-seq data from excitatory neurons. We also generated a brain-specific gene-coregulation network that we used to predict which genes have brain-specific functions, and to perform a novel network analysis of Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and Parkinson’s disease (PD) GWAS data. This resulted in the identification of distinct sets of genes that show significantly enriched co-regulation with genes inside the associated GWAS loci, and which might reflect drivers of these diseases. ### Competing Interest Statement Ellen A. Tsai, Denis Baird, Yunfeng Huang, Chia-Yen Chen, Zhengyu Ouyang, Eric E. Marshall, Maria I. Zavodszky, and Heiko Runz are full time employees and hold stock options at Biogen